These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37068580)

  • 21. Grafting of functional motifs onto protein scaffolds identified by PDB screening--an efficient route to design optimizable protein binders.
    Tlatli R; Nozach H; Collet G; Beau F; Vera L; Stura E; Dive V; Cuniasse P
    FEBS J; 2013 Jan; 280(1):139-59. PubMed ID: 23121732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
    Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
    Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain.
    Kothapalli R; Khan AM; Basappa ; Gopalsamy A; Chong YS; Annamalai L
    PLoS One; 2010 Aug; 5(8):e12494. PubMed ID: 20824169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.
    Shirian J; Hockla A; Gleba JJ; Coban M; Rotenberg N; Strik LM; Alasonyalilar Demirer A; Pawlush ML; Copland JA; Radisky ES; Shifman JM
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).
    Higashi S; Hirose T; Takeuchi T; Miyazaki K
    J Biol Chem; 2013 Mar; 288(13):9066-76. PubMed ID: 23395821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
    Mendes DE; Wong-On-Wing A; Berkman CE
    J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered Peptide Macrocycles Can Inhibit Matrix Metalloproteinases with High Selectivity.
    Maola K; Wilbs J; Touati J; Sabisz M; Kong XD; Baumann A; Deyle K; Heinis C
    Angew Chem Int Ed Engl; 2019 Aug; 58(34):11801-11805. PubMed ID: 31251434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell.
    Arkadash V; Radisky ES; Papo N
    Oncotarget; 2018 Aug; 9(62):32036-32053. PubMed ID: 30174795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)).
    Bahudhanapati H; Zhang Y; Sidhu SS; Brew K
    J Biol Chem; 2011 Sep; 286(36):31761-70. PubMed ID: 21715326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
    El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
    Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
    Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
    J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of small molecule inhibitors against MMP-14 via High-Throughput screening.
    Lee H; Youn I; Demissie R; Vaid TM; Che CT; Azar DT; Han KY
    Bioorg Med Chem; 2023 May; 85():117289. PubMed ID: 37094433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
    Huang W; Meng Q; Suzuki K; Nagase H; Brew K
    J Biol Chem; 1997 Aug; 272(35):22086-91. PubMed ID: 9268350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.
    Lopez T; Chuan C; Ramirez A; Chen KE; Lorenson MY; Benitez C; Mustafa Z; Pham H; Sanchez R; Walker AM; Ge X
    Biotechnol Bioeng; 2018 Nov; 115(11):2673-2682. PubMed ID: 30102763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.
    Kang SG; Araya-Secchi R; Wang D; Wang B; Huynh T; Zhou R
    Sci Rep; 2014 Apr; 4():4775. PubMed ID: 24758941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.
    Scannevin RH; Alexander R; Haarlander TM; Burke SL; Singer M; Huo C; Zhang YM; Maguire D; Spurlino J; Deckman I; Carroll KI; Lewandowski F; Devine E; Dzordzorme K; Tounge B; Milligan C; Bayoumy S; Williams R; Schalk-Hihi C; Leonard K; Jackson P; Todd M; Kuo LC; Rhodes KJ
    J Biol Chem; 2017 Oct; 292(43):17963-17974. PubMed ID: 28860188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening.
    Gimeno A; Cuffaro D; Nuti E; Ojeda-Montes MJ; Beltrán-Debón R; Mulero M; Rossello A; Pujadas G; Garcia-Vallvé S
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.